Download FREE Sample
Cannabidiol (CBD) is a natural compound found in Cannabis sativa plants, including hemp and marijuana. Unlike tetrahydrocannabinol (THC), CBD is non-psychoactive, and is primarily known for its potential therapeutic effects. CBD interacts with the body-s endocannabinoid system, which regulates processes like pain, mood, and immune response. Known for its potential therapeutic effects, CBD is widely used to alleviate anxiety, pain, and inflammation, and it-s incorporated into various products, including oils, edibles, creams, and supplements. Its popularity is rising due to its perceived health benefits, though research is ongoing, and regulatory status varies across countries and regions.
To learn more about this report, download the PDF brochure
Increasing consumer awareness and acceptance of CBD-s potential therapeutic benefits to propel market demand
Increasing consumer awareness and acceptance of CBD's potential therapeutic benefits is a key driver in the cannabidiol market. As studies and testimonials highlight CBD-s ability to alleviate issues like anxiety, chronic pain, and inflammation, consumers are increasingly open to trying CBD products. Additionally, the perception of CBD as a natural, non-psychoactive remedy distinguishes it from THC, appealing to health-conscious and wellness-oriented consumers. CBD-s incorporation into various products, such as oils, edibles, cosmetics, and supplements, further broadens its reach. This growing acceptance, combined with product diversity, is accelerating market growth and expanding CBD-s consumer base worldwide.
Growing legalization of cannabis and CBD productstrong>
The growing legalization of cannabis and CBD products is significantly driving the cannabidiol market by opening up regulated pathways for production, distribution, and consumption. In regions like the US, Canada, and parts of Europe, legal reforms have increased CBD-s accessibility, enabling businesses to operate transparently and expand offerings across wellness, healthcare, and personal care. Legalization also boosts consumer confidence, as regulated products undergo quality and safety testing. Furthermore, emerging markets in Latin America and Asia-Pacific are following suit, creating new growth opportunities for CBD companies. This global shift in policy fosters market expansion and supports innovation in CBD products.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global cannabidiol market is marked by the presence of established and emerging market players such as Medical Marijuana, Inc., Canopy Growth Corporation, PharmaHemp, ENDOCA, Folium Europe B.V., Isodiol International Inc., Gaia Botanics, NuLeaf Naturals, LLC, Elixinol, and Joy Organics; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Year | 2025 - 2030 |
| Growth Rate | CAGR of 16% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Application, Source, Distribution Channel |
| Regional Scope |
|
| Key Companies Mapped | Medical Marijuana, Inc., Canopy Growth Corporation, PharmaHemp, ENDOCA, Folium Europe B.V., Isodiol International Inc., Gaia Botanics, NuLeaf Naturals, LLC, Elixinol, and Joy Organics among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Cannabidiol Market Segmentation
This report by Medi-Tech Insights provides thesize of the global cannabidiol market at theregional- and country-level from 2023 to 2030. The report further segments the market based on product, application, source, and distribution channel.
- Market Size & Forecast (2023-2030), By Product, USD Million
- Oils and Tinctures
- Edibles
- Edibles
- Capsules and Soft gels
- Topicals
- Others
- Market Size & Forecast (2023-2030), By Application, USD Million
- Medical and Pharmaceutical Applications
- Pain Management
- Mental Disorders
- Neurological Disorders
- Cancer
- Other Medical Applications
- Wellness and Personal Care
- ges
- Nutraceuticals
- Veterinary Care
- Others
- Medical and Pharmaceutical Applications
- Market Size & Forecast (2023-2030), By Source, USD Million
- Hemp-Derived
- Marijuana-Derived
- Market Size & Forecast (2023-2030), By Distribution Channel, USD Million
- Online Retail
- Pharmacies
- Specialty Stores
- Convenience Stores and Supermarkets
- Others
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Frequently Asked Questions About This Report
What is the market size & forecast of the cannabidiol market?
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the cannabidiol market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
